Opiant Pharmaceuticals Inc (OPNT)
Market Closed
1 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
20. 65
0
0%
$
108.8M Market Cap
- P/E Ratio
- Div Yield
562,778 Volume
- Eps
$ 20.65
Previous Close Investors:
Want to track OPNT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Opiant Pharmaceuticals Inc (OPNT) Statistics
Valuation metrics
Market Cap 108.8M
Enterprise value 88.02M
Trailing P/E (ttm) 30.37
Forward P/E -
PEG ratio 0.84
Price/Sales (ttm) 2.67
Price/Book (mrq) 1.96
Enterprise Value/Revenue 2.16
Enterprise Value/EBITDA 15.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 7.34
52-Week high 27.36
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 31 Dec 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.04%
Return on equity 0.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 9.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 11.86
Total debt (mrq) -
Total Debt/Equity (mrq) 0.36
Current ratio (mrq) 10.1%
Book value per share (mrq) 10.51
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
